25/5 Logo (Glyxambi empagliflozin 25 mg / linagliptin 5 mg)
Generic Name: empagliflozin/linagliptin
Pill imprint 25/5 Logo has been identified as Glyxambi empagliflozin 25 mg / linagliptin 5 mg.
Glyxambi is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glyxambi empagliflozin 25 mg / linagliptin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 25/5 Logo
- empagliflozin 25 mg / linagliptin 5 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
More about Glyxambi (empagliflozin / linagliptin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.